Syn­lait Milk in­vests in state-of-the-art test­ing lab

DEMM Engineering & Manufacturing - - FOOD -

Syn­lait Milk, which is still sore from the wound in­flicted by Fon­terra’s bot­u­lism scare, is build­ing a state-of-the-art full ser­vice test­ing lab­o­ra­tory to sup­port its po­si­tion as a sup­plier of high qual­ity value added in­gre­di­ents, in­fant for­mula and nu­tri­tional prod­ucts.

The com­pany’s qual­ity strat­egy has been to build in-house ca­pa­bil­i­ties to sup­port the test­ing re­quire­ments for the prod­ucts it pro­duces. How­ever, it has now sig­nif­i­cantly ex­panded the scope of the pro­posed lab­o­ra­tory from chemical and phys­i­cal property test­ing to in­clude full mi­cro­bi­o­log­i­cal test­ing us­ing the lat­est tech­nolo­gies.

In ad­di­tion to the qual­ity test­ing func­tion there will now also be in­te­grated fa­cil­i­ties to sup­port new prod­uct de­vel­op­ment, in­clud­ing the abil­ity to con­duct pi­lot scale tri­als, as well as al­low­ing for sen­sory anal­y­sis to en­sure the needs of the Com­pany’s cus­tomers are met.

Syn­lait Milk man­ag­ing di­rec­tor John Penno says the change in scope will give Syn­lait Milk greater con­trol over the qual­ity test­ing process and help en­sure it can achieve the ever in­creas­ing qual­ity stan­dards re­quired by the world’s most de­mand­ing cus­tomers. It will also re­duce the need for ex­ter­nal ser­vices and as­so­ci­ated costs while re­duc­ing turn­around times.

“By build­ing ca­pa­bil­ity in qual­ity man­age­ment and es­tab­lish­ing an on-site ‘cen­tre of ex­cel­lence’ that will be ac­cred­ited to in­ter­na­tional stan­dards, the com­pany will strengthen its rep­u­ta­tion with cus­tomers and the reg­u­la­tory bod­ies gov­ern­ing the mar­kets it serves,” said Penno.

Syn­lait Milk has also changed the scope of its new ad­min­is­tra­tion fa­cil­ity in­cor­po­rat­ing ex­tra ca­pac­ity to sup­port growth in the busi­ness over­time. This will ce­ment Dun­sandel as the head­quar­ters for the film.

Due to the change in scope of both the qual­ity test­ing lab­o­ra­tory and the ad­min­is­tra­tion fa­cil­ity an additional cap­i­tal ex­pen­di­ture is re­quired. The com­pany’s board has ap­proved a to­tal com­bined cost fore­cast to be $21m, with a com­ple­tion date for both fa­cil­i­ties ex­pected to be Fe­bru­ary 2015.

Syn­lait Milk’s fore­cast net profit af­ter tax for FY2014 will be sig­nif­i­cantly ahead of its prospec­tus fore­cast of $19.8mn, and is ex­pected to be in the range of $30m to $35m.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.